Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arterial Remodeling Technologies
Bioresorbable Stent Company, Arterial Remodeling Technologies (''ART''), Leases Manufacturing Facility
February 2nd, 2008
Arterial Remodeling Technologies ("ART") announced that it has leased a manufacturing facility (20,000 square feet) as a result of mastering proprietary polymer-based manufacturing technology to produce bioresorbable stents. The company's bioresorbable stents, which can be manufactured at very low cost, are designed to dismantle in vivo over an optimized time horizon, thus allowing the body's natural arterial remodeling process to occur, which is normally restricted by the deployment of permanent metallic stents. In November 2007, ART announced that it had closed on a new venture financing round of EUR 5.5 ($7.8) million from investors Matignon Technologies and SGAM...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2008-02-02)
|
